Novartis Wins FDA Approval For Novel Psoriasis Drug
The U.S. Food and Drug Administration has given the go ahead for Novartis AG to begin manufacturing and selling a drug that promises to rid suffers of moderate to severe psoriasis...To view the full article, register now.
Already a subscriber? Click here to view full article